Advertisement

Author: Staff

While the orthopedic specialty wasn't as ravaged by COVID-19 as gastroenterology or oral surgery, it experienced a "substantial" drop in utilization and revenue, according to Fair Health's 2020 "Healthcare Professionals and the Impact of COVID-19" report, a comparative study of…

Advertisement

Medtronic's $9 billion minimally invasive therapies group — the company's second-largest business line — has ventilators, remote patient monitoring tools and minimally invasive surgery devices in the pipeline for the rest of the year, according to Bob White, group president.

Advertisement